Recently, PCNSL has been related to the so-called ‘MCD’ subgroup [3], which is a genetic subset of lymphomas with gain-of-function mutations in both MYD88 L265P and CD79B [23]. Here, MYD88 is linked to primary central nervous system lymphoma.